CVS Health exceeded second-quarter earnings and revenue estimates and raised its full-year guidance, driven by better-than-expected medical costs in its Aetna insurance business. The results signal improvement in the struggling insurance division.
Americans are expected to spend more than $1 trillion on prescription drugs in 2026, according to a new report from the American Society of Health-System Pharmacists. The surge is largely attributed to the growing popularity of GLP-1 weight-loss drugs.
A Harvard-backed study found that the Inflation Reduction Act's drug provisions are helping Medicare beneficiaries stay on their medications. However, the reforms have not yet reduced overall healthcare costs or financial anxiety for beneficiaries.
Health insurance premiums for Affordable Care Act marketplace plans are projected to rise by a median of 14% in 2027 according to preliminary insurer filings analyzed by KFF, marking the second straight year of double-digit increases and creating significant cost pressures for middle-income Americans.
